CHELSEA AUSTEN: Open Payments
NPI 1346608627 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,212 in 215 payments from 17 companies in 2025. Trend: 2023 $3,756 · 2024 $4,128 · 2025 $10,212
Food & beverage: $4,314Consulting: $3,365Travel & lodging: $2,443Education: $90
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $6,684 |
| ABBVIE INC. | 61 | $1,076 |
| Janssen Biotech, Inc. | 29 | $676 |
| Amgen Inc. | 49 | $633 |
| UCB, Inc. | 17 | $310 |
| AstraZeneca Pharmaceuticals LP | 5 | $220 |
| Lilly USA, LLC | 5 | $140 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| Organon LLC | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $64 |
Products named: COSENTYX, RINVOQ, TREMFYA, Bimzelx, SKYRIZI, EVENITY, SAPHNELO, TAVNEOS.
Industry payments across OH — which companies pay providers there.
